Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Endocrinology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2003-0105PMID 14684847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression.

  2003cited by this paper
• Estrogen receptor α and Sp1 regulate progesterone receptor gene expression

  2003cited by this paper
• Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.

  2002cited by this paper
• Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.

  2002cited by this paper
• Estrogen Receptor α and Activating Protein-1 Mediate Estrogen Responsiveness of the Progesterone Receptor Gene in MCF-7 Breast Cancer Cells

  2002cited by this paper
• Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions.

  2001cited by this paper
• Mobility Shift DNA‐Binding Assay Using Gel Electrophoresis

  2001cited by this paper
• Characterization of the Physical Interaction between Estrogen Receptor α and JUN Proteins*

  2001cited by this paper
• Allosteric modulation of estrogen receptor conformation by different estrogen response elements.

  2001cited by this paper
• Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.

  2001cited by this paper
• Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter.

  2000cited by this paper
• Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

  2000cited by this paper
• Estrogen receptor pathways to AP-1.

  2000cited by this paper
• The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.

  1999cited by this paper
• Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.

  1999cited by this paper
• The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions

  1997cited by this paper
• A role for oestrogens in the male reproductive system

  1997cited by this paper
• The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens

  1997cited by this paper
• Progesterone receptor A and B protein expression in human breast cancer.

  1996cited by this paper
• Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

  1995cited by this paper
• Steroid hormone receptors: many actors in search of a plot.

  1995cited by this paper
• Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.

  1994cited by this paper
• Nucleic acid sequence and DNase hypersensitive sites of the 5' region of the mouse progesterone receptor gene.

  1994cited by this paper
• Insights from the study of animals lacking functional estrogen receptor.

  1994cited by this paper
• Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene.

  1994cited by this paper
• Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.

  1993cited by this paper
• Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

  1992cited by this paper
• The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene.

  1992cited by this paper
• The limits of the cellular capacity to mediate an estrogen response.

  1992cited by this paper
• Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

  1991cited by this paper
• The AP-1 complex and its role in transcriptional control by protein kinase C

  1991cited by this paper
• Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.

  1991cited by this paper
• Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

  1991cited by this paper
• Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells.

  1991cited by this paper
• Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity.

  1991cited by this paper
• Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.

  1990cited by this paper
• DNA‐binding activity of jun is increased through its interaction with Fos

  1990cited by this paper
• A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly.

  1990cited by this paper
• Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly.

  1990cited by this paper
• Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.

  1990cited by this paper
• Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex.

  1990cited by this paper
• Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures

  1989cited by this paper
• Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation.

  1988cited by this paper
• Fos and Jun: the AP-1 connection.

  1988cited by this paper
• The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.

  1988cited by this paper
• Fos-associated protein p39 is the product of the jun proto-oncogene.

  1988cited by this paper
• Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.

  1988cited by this paper
• Organisation of the entire rabbit progesterone receptor mRNA and of the promoter and 5' flanking region of the gene.

  1988cited by this paper
• Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.

  1988cited by this paper
• Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum

  1987cited by this paper
• Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

  1987cited by this paper
• Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

  1987cited by this paper
• Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro.

  1987cited by this paper
• Viral and cellular fos proteins: a comparative analysis.

  1984cited by this paper
• Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.

  1984cited by this paper

• Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study

  2024cites this paper
• miR-19b-3p regulated by estrogen controls lipid synthesis through targeting MSMO1 and ELOVL5 in LMH cells

  2023cites this paper
• An Innovative Non-Hormonal Strategy Targeting Redox Active Metals to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer

  2023cites this paper
• Innovative Thiosemicarbazones that Induce Multi-Modal Mechanisms to Down-Regulate Estrogen-, Progesterone-, Androgen- and Prolactin-Receptors in Breast Cancer.

  2023cites this paper
• Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system.

  2022cites this paper
• The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer

  2021cites this paper
• Elucidating evolutionarily conserved mechanisms of diapause regulation using an in silico approach

  2021cites this paper
• Role of α-Peltatin as a new Cofactor of Estrogen receptor interaction in the treatment of Ovarian cancer

  2021cites this paper
• Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor‐positive breast cancer patients

  2020cites this paper
• Estrogen Abolishes the Repression Role of gga-miR-221-5p Targeting ELOVL6 and SQLE to Promote Lipid Synthesis in Chicken Liver

  2020cites this paper
• miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas

  2020cites this paper
• Inhibiting pathways predicted from a steroid hormone gene signature yields synergistic anti-tumor effects in non-small cell lung cancer.

  2019cites this paper
• Genome-Wide Analysis of the FABP Gene Family in Liver of Chicken (Gallus gallus): Identification, Dynamic Expression Profile, and Regulatory Mechanism

  2019cites this paper
• Meta‐analysis of the impact of progesterone receptor status on oncological outcomes in oestrogen receptor‐positive breast cancer

  2019cites this paper
• C/EBPβ LIP and c-Jun synergize to regulate expression of the murine progesterone receptor.

  2018cites this paper
• Dynamic Expression Profile, Regulatory Mechanism and Correlation with Egg-laying Performance of ACSF Gene Family in Chicken (Gallus gallus)

  2018cites this paper
• Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome

  2017cites this paper
• Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome.

  2017cites this paper
• 3.10 – Mechanism of Progesterone Action in the Brain

  2017cites this paper
• Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

  2016influential citation
• Identification of DNA sequence variants in the estrogen receptor pathway in breast cancer

  2016cites this paper
• Uterine responses to feeding soy protein isolate and treatment with 17β-estradiol differ in ovariectomized female rats.

  2016cites this paper
• Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus

  2016cites this paper
• Targeting Estrogen Receptor Negative Breast Cancer Cells Using Diarylthiourea Analogs of SHetA2

  2016cites this paper
• Efecto del tamoxifeno, raloxifeno y toremifeno sobre la actividad y expresión del receptor de LDL en linfocitos primarios humanos

  2016cites this paper
• Expression of estrogen receptor α in the mouse cerebral cortex.

  2015cites this paper
• Altered Biological Characteristics of Eutopic and Ectopic Endometrium

  2014cites this paper
• Endocrine therapy resistance: current status, possible mechanisms and overcoming strategies.

  2013cites this paper
• TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

  2013cites this paper
• Feeding soy protein isolate and treatment with estradiol have different effects on mammary gland morphology and gene expression in weanling male and female rats.

  2013cites this paper
• HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases

  2012cites this paper
• Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.

  2012cites this paper
• Role of Estrogen Receptor-β in Endometriosis

  2012cites this paper
• Progesterone receptors, their isoforms and progesterone regulated transcription.

  2012cites this paper
• Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells

  2012cites this paper
• Cutting SRC-1 down to size in endometriosis

  2012cites this paper
• Estrogen regulation of human with-no-lysine (K) kinase-4 gene expression involves AP-1 transcription factor.

  2011cites this paper
• Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen

  2011cites this paper
• Familial and Sporadic Breast Cancers

  2011cites this paper
• Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis.

  2010cites this paper
• Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence

  2010cites this paper
• Simultaneous targeting of estrogen receptor and HER2 in breast cancer

  2010cites this paper
• Early and late tamoxifen resistance in breast cancer

  2010cites this paper
• Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.

  2010cites this paper
• Long-range transcriptional control of progesterone receptor gene expression.

  2010cites this paper
• Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis

  2010cites this paper
• Complex prolactin crosstalk in breast cancer: new therapeutic implications.

  2009cites this paper
• Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

  2009cites this paper
• Tumorigenesis and Neoplastic Progression Prolactin–Growth Factor Crosstalk Reduces Mammary Estrogen Responsiveness Despite Elevated ER Expression

  2009cites this paper
• Hormone resistance.

  2009cites this paper
• Endocrine Resistance in Breast Cancer- Where Are We NowWith Intelligent Combination Therapies?

  2009cites this paper
• The AF-1 and hinge region of the human Estrogen Receptor cooperate in the quantitative response to estradiol and tamoxifen

  2009cites this paper
• Bioassays for the detection of hormonal activities.

  2009cites this paper
• Enhancing the efficacy of hormonal agents with selected targeted agents.

  2009cites this paper
• Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.

  2009cites this paper
• The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor alpha mediated gene expression.

  2008cites this paper
• 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.

  2008cites this paper
• Comparative effects of oral conjugated equine estrogens and micronized 17&bgr;-estradiol on breast proliferation: a retrospective analysis

  2008cites this paper
• Progesterone receptor isoform functions in normal breast development and breast cancer.

  2008cites this paper
• Developmental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat

  2008cites this paper
• Rho GDP dissociation inhibitor a interacts with estrogen receptor a and influences estrogen responsiveness

  2007cites this paper
• Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.

  2007cites this paper
• Interaction of estrogen receptor α with proliferating cell nuclear antigen

  2007cites this paper
• Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

  2007cites this paper
• The deoxyribonucleic acid repair protein flap endonuclease-1 modulates estrogen-responsive gene expression.

  2007cites this paper
• Rho GDP dissociation inhibitor alpha interacts with estrogen receptor alpha and influences estrogen responsiveness.

  2007cites this paper
• Adjuvant hormonal therapy in peri- and postmenopausal breast cancer.

  2006cites this paper
• Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression.

  2006influential citation
• Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer

  2006cites this paper
• Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

  2006cites this paper
• The AP-1 transcription factor regulates postnatal mammary gland development.

  2006cites this paper
• Protein Disulfide Isomerase Serves as a Molecular Chaperone to Maintain Estrogen Receptor α Structure and Function

  2006cites this paper
• Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis

  2006cites this paper
• Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.

  2006cites this paper
• Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor alpha structure and function.

  2006cites this paper
• Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression

  2006influential citation
• Estrogen Receptor (ER) β Modulates ERα-Mediated Transcriptional Activation by Altering the Recruitment of c-Fos and c-Jun to Estrogen-Responsive Promoters

  2006cites this paper
• Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.

  2006cites this paper
• Effects of Soybean Glyceollins and Estradiol in Postmenopausal Female Monkeys

  2006influential citation
• Effects of High-Dose Soy Isoflavones and Equol on Reproductive Tissues in Female Cynomolgus Monkeys1

  2006cites this paper
• Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

  2006cites this paper
• Cell- and ligand-specific regulation of promoters containing activator protein-1 and Sp1 sites by estrogen receptors alpha and beta.

  2005cites this paper
• Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.

  2005cites this paper
• Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.

  2005cites this paper
• Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer.

  2005cites this paper
• Molecular insights into endocrine resistance.

  2005cites this paper
• Aromatase inhibitors: future directions.

  2005cites this paper
• Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

  2005cites this paper
• Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

  2005cites this paper
• Regulation of E2F-1 gene expression in human breast cancer cells

  2005cites this paper
• Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

  2005cites this paper
• Cell- and Ligand-specific Regulation of Promoters Containing Activator Protein-1 and Sp1 Sites by Estrogen Receptors α and β*

  2005cites this paper